Diag Capital Management »

Medtronic shares owned by Diag Capital Management

Quarter-by-quarter ownership of Medtronic (MDT) shares owned by Diag Capital Management from 13F filings

Historical chart of Diag Capital Management investment in Medtronic

Tip: Access up to 7 years of quarterly data

All positions including Medtronic held by Diag Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Medtronic by Diag Capital Management

Quarter filed Position value Share count Share price at filing
2018-12-31 $3.3M 36k 90.96

More positions owned by Diag Capital Management

Baxter International (BAX)
Athenex
Zimmer Holdings (ZBH)
Abbvie (ABBV)
Incyte Corporation (INCY)
Quanterix Ord (QTRX)
Celgene Corporation
Amgen (AMGN)
Foamix Pharmaceuticals
Medtronic (MDT)
Quotient
Pacira Pharmaceuticals conv
Takeda Pharmaceutical (TAK)
Abbott Laboratories (ABT)
Zai Lab (ZLAB)

View all positions for Diag Capital Management

Top funds holding Medtronic

Vanguard Group
BlackRock
Jpmorgan Chase & Co
Morgan Stanley
Geode Capital Management
Massachusetts Financial Services
Wellington Management Company
Bank of America Corporation
Bank of New York Mellon
Franklin Resources
Deutsche Bank Aktiengesellschaft
T. Rowe Price Associates
Royal Bank of Canada
Sanders Capital
Northern Trust

View all funds holding Medtronic